What is the treatment for bacterial meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Meningitis

Immediate Management: Time is Brain

Antibiotic therapy must be initiated within 1 hour of presentation for suspected bacterial meningitis, as delay is strongly associated with increased mortality and poor neurological outcomes. 1, 2

Critical First Steps (Within 60 Minutes)

  • Obtain blood cultures immediately before antibiotics, but never delay antibiotic administration beyond 1 hour waiting for cultures or imaging 1, 2
  • If lumbar puncture is delayed for any reason (need for CT imaging, coagulopathy, hemodynamic instability), start empiric antibiotics immediately on clinical suspicion 1, 3
  • Administer adjunctive dexamethasone 10 mg IV every 6 hours (or 0.15 mg/kg every 6 hours in children) 10-20 minutes before or simultaneously with the first antibiotic dose 4, 2

Empiric Antibiotic Regimens by Age and Risk Factors

Neonates (0-3 months)

  • Ampicillin 50 mg/kg IV every 6-8 hours PLUS cefotaxime 50 mg/kg IV every 6-8 hours 2
  • This regimen covers Group B Streptococcus, E. coli, and Listeria monocytogenes 1

Children (3 months to <18 years)

  • Ceftriaxone 50 mg/kg IV every 12 hours (maximum 2g every 12 hours) OR cefotaxime 75 mg/kg IV every 6-8 hours PLUS vancomycin 10-15 mg/kg IV every 6 hours (target trough 15-20 mg/mL) 1, 2
  • For bacterial meningitis in pediatric patients ≥3 months, meropenem 40 mg/kg every 8 hours (maximum 2 grams every 8 hours) is FDA-approved for H. influenzae, N. meningitidis, and penicillin-susceptible S. pneumoniae 5

Adults <50 Years Without Immunocompromise

  • Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 4-6 hours PLUS vancomycin 15-20 mg/kg IV every 8-12 hours (target trough 15-20 mg/mL) 4, 1, 2
  • Vancomycin is essential in areas with high pneumococcal resistance to penicillin 1

Adults ≥50 Years or Immunocompromised

  • Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 4-6 hours PLUS vancomycin 15-20 mg/kg IV every 8-12 hours PLUS ampicillin 2g IV every 4 hours 1, 2
  • The addition of ampicillin is critical for Listeria monocytogenes coverage, as this pathogen is not covered by cephalosporins 1, 2
  • Risk factors for Listeria include age >50 years, diabetes mellitus, immunosuppressive drugs, cancer, and other immunocompromising conditions 1

Adjunctive Dexamethasone Therapy

Dexamethasone reduces mortality and neurological sequelae in pneumococcal meningitis and should be administered to all adults and children with suspected bacterial meningitis. 4, 2

Administration Protocol

  • Give dexamethasone 10 mg IV every 6 hours (0.15 mg/kg every 6 hours in children) before or with the first antibiotic dose 4, 2
  • Continue for 2-4 days if pneumococcal or H. influenzae meningitis is confirmed 2
  • Discontinue if Pseudomonas is identified, as dexamethasone may worsen outcomes in gram-negative meningitis 2

Evidence Base

  • A Cochrane meta-analysis of 25 RCTs including 4,121 patients found that corticosteroids decreased overall hearing loss and neurological sequelae, and reduced mortality specifically in pneumococcal meningitis 4
  • The benefit was observed in high-income countries with high standards of medical care, but not in low-income settings 4

Pathogen-Specific Definitive Therapy

Once culture and susceptibility results are available, narrow antibiotic therapy:

Streptococcus pneumoniae (Penicillin-Sensitive)

  • Penicillin G 24 million units/day IV (divided every 4 hours) OR continue ceftriaxone 2g IV every 12 hours for 10-14 days 2

Streptococcus pneumoniae (Penicillin-Resistant or Unknown Susceptibility)

  • Continue ceftriaxone 2g IV every 12 hours PLUS vancomycin 15-20 mg/kg IV every 8-12 hours for 10-14 days 2

Neisseria meningitidis

  • Penicillin G 24 million units/day IV OR ceftriaxone 2g IV every 12 hours for 5-7 days 2
  • Give a single dose of ciprofloxacin 500 mg PO for nasopharyngeal eradication before discharge 4, 2

Listeria monocytogenes

  • Ampicillin 2g IV every 4 hours (12g total daily dose) for 21 days 2
  • Gentamicin may be added for synergy in severe cases, though evidence is limited 2

Haemophilus influenzae

  • Continue ceftriaxone or cefotaxime for 10 days 2

Pseudomonas aeruginosa

  • Ceftazidime 2g IV every 8 hours PLUS tobramycin 3-5 mg/kg/day IV divided every 8 hours for 21 days 2
  • If associated with neurosurgical hardware or shunt, removal is typically necessary 2

Indications for CT Before Lumbar Puncture

Perform CT scan before lumbar puncture if any of the following are present:

  • Age ≥60 years 1
  • Immunocompromised state 1
  • History of CNS disease (mass lesion, stroke, focal infection) 1
  • New-onset seizures within 1 week 1
  • Altered mental status (Glasgow Coma Scale <12) 1
  • Focal neurological deficits 1
  • Papilledema 1

Critical caveat: If CT is indicated, start empiric antibiotics and dexamethasone BEFORE sending the patient for imaging 1, 3. Only perform lumbar puncture after CT if there is no mass effect or elevated intracranial pressure 1.


Prophylaxis for Close Contacts

Meningococcal Meningitis

All close contacts must receive antibiotic prophylaxis within 24 hours of case identification to prevent secondary cases and eradicate nasopharyngeal carriage. 4

  • Ciprofloxacin 500 mg PO single dose (preferred for adults) 4
  • Ceftriaxone 250 mg IM single dose (preferred for pregnant women and children) 4
  • Rifampicin 600 mg PO every 12 hours for 2 days (alternative) 4

Close contacts include household members, child care center contacts, and anyone directly exposed to oral secretions 4. The risk of meningococcal disease is increased 400-800-fold in close contacts 4.

Pneumococcal Meningitis

  • Vaccinate patients after recovery with pneumococcal vaccine to reduce recurrence risk of 1-5% 4
  • Vaccination is especially important in patients with CSF leakage 4

Adjunctive Therapies NOT Recommended

The ESCMID guideline explicitly advises against several adjunctive therapies:

  • Glycerol is contraindicated in bacterial meningitis (associated with worse outcomes in adults) 4
  • Therapeutic hypothermia is contraindicated (associated with higher mortality) 4
  • Routine use of mannitol, acetaminophen, antiepileptic drugs, or hypertonic saline is not recommended 4
  • Immunoglobulins, heparin, and activated protein C are not recommended 4

Common Pitfalls to Avoid

  • Delaying antibiotics for imaging: Never wait for CT results before starting antibiotics if bacterial meningitis is suspected 1, 2
  • Inadequate Listeria coverage: Always add ampicillin for patients ≥50 years or immunocompromised 1, 2
  • Insufficient antibiotic dosing: Use high-dose regimens to ensure adequate CSF penetration (ceftriaxone 2g every 12 hours, not lower doses) 2
  • Neglecting blood cultures: Always obtain blood cultures before antibiotics, but never delay treatment to do so 1, 2
  • Forgetting dexamethasone: Administer before or with the first antibiotic dose for maximum benefit 4, 2
  • Premature discontinuation: Complete the full duration of therapy (5-21 days depending on pathogen) 2

Duration of Antibiotic Therapy

  • N. meningitidis: 5-7 days 2
  • H. influenzae: 10 days 2
  • S. pneumoniae: 10-14 days 4, 2
  • Listeria monocytogenes: 21 days 2
  • Pseudomonas aeruginosa: 21 days 2
  • Unknown pathogen (culture-negative): Minimum 14 days with empiric regimen 4

The ESCMID guideline does not recommend short-course antibiotic therapy (5 days) in European settings, despite evidence from resource-limited settings, due to differences in epidemiology and comorbidities 4.

References

Guideline

Treatment of Bacterial Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bacterial Meningitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.